Abstract：
The revolution that we are seeing in the world of surgery will determine the way we understand surgical approaches in coming years. Since the implementation of minimally invasive surgery, innovations have constantly been developed to allow the laparoscopic approach to go further and be applied to more and more procedures. In recent years, we have been in the middle of another revolutionary era, with robotic surgery, the application of artificial intelligence and image-guided surgery. The latter includes 3D reconstructions for surgical planning, virtual reality, holograms or tracer-guided surgery, where ICG-guided fluorescence has provided a different perspective on surgery. ICG has been used to identify anatomical structures, assess tissue perfusion, and identify tumors or tumor lymphatic drainage. But the most important thing is that this technology has come hand in hand with the potential to develop other types of tracers that will facilitate the identification of tumor cells and ureters, as well as different light beams to identify anatomical structures. These will lead to other types of systems to assess tissue perfusion without the use of tracers, such as hyperspectral imaging. Combined with the upcoming introduction of ICG quantification, these developments represent a real revolution in the surgical world. With the imminent implementation of these technological advances, a review of their clinical application in general surgery is timely, and this review serves that aim.
摘要：
我们在外科领域看到的革命将决定我们在未来几年理解外科方法的方式。自从实施微创手术以来,不断发展的创新，以使腹腔镜方法走得更远，并应用于越来越多的程序。近年来,我们正处于另一个革命时代，机器人手术，人工智能和图像引导手术的应用。后者包括用于手术计划的3D重建，虚拟现实,全息图或示踪剂引导的手术，其中ICG引导的荧光为手术提供了不同的视角。ICG已用于识别解剖结构，评估组织灌注，并识别肿瘤或肿瘤淋巴引流。但最重要的是，这项技术与开发其他类型的示踪剂的潜力齐头并进，这些示踪剂将有助于识别肿瘤细胞和输尿管，以及不同的光束来识别解剖结构。这些将导致其他类型的系统在不使用示踪剂的情况下评估组织灌注，如高光谱成像。结合即将推出的ICG量化，这些发展代表了外科世界的一场真正的革命。随着这些技术进步的实施迫在眉睫，及时回顾其在普外科中的临床应用，这次审查符合这一目标。
